Use of TNF alpha inhibitors in Crohn's disease associated with higher risk of MS
Dr. Jay Avasarala, professor of neurology and director of the University of Kentucky's Multiple Sclerosis Clinic, and co-authors, conducted a retrospective study in which they evaluated approximately 96.5 million enrollees ...
May 12, 2021
0
1